Viewing Study NCT00121134


Ignite Creation Date: 2025-12-25 @ 2:33 AM
Ignite Modification Date: 2025-12-31 @ 8:15 PM
Study NCT ID: NCT00121134
Status: COMPLETED
Last Update Posted: 2013-12-24
First Post: 2005-07-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Sponsor: Harold J. Burstein, MD, PhD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-06
Start Date Type: None
Primary Completion Date: 2009-05
Primary Completion Date Type: ACTUAL
Completion Date: 2011-05
Completion Date Type: ACTUAL
First Submit Date: 2005-07-13
First Submit QC Date: None
Study First Post Date: 2005-07-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-08-08
Results First Submit QC Date: None
Results First Post Date: 2013-10-14
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-11-26
Last Update Post Date: 2013-12-24
Last Update Post Date Type: ESTIMATED